!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
Bases!neurophysiologiques!dans!les!troubles!psychiques.!
Effets!de!l’(électro)acupuncture!sur!l’homéostasie!des!neuromédiateurs.!!
!"#$%&'&("#)*&+,(-.#/,(0-120&3%3+&(4#56*7*,6-*"(4#5*"&6*%3-12"57&(.#
Références.!
!
!839:"(*;#2%29(,-0#<&06*-20#<5,0#%(#-(;-(#7"3'&(,,(,-#<*#%&'"(#=#
>%(6-"356*7*,6-*"(4#5#7"56-&65%#95,*5%#?#"(03*"6(4#@5A3".#)1*"61&%%#B&'&,+0-3,(4#CDDE.#
B5#:50(#<(#<3,,2(0#<*#)!#F39#<(#6(-#3*'"5+(#63,-&(,-#-3*-(0#%(0#"2G2"(,6(0#<(0#2-*<(0#
H*&#03*0I-(,<(,-#%(#-(;-(#<(#6(#-"5'5&%.#
#
Conclusions!
#
B(0#75-&(,-0#H*&#(;72"&9(,-(,-#<(#%5#"(%5;5-&3,#(-#9J9(#<*#7%5&0&"#%3"0#<K*,(#
025,6(#<K56*7*,6-*"(#,(#03,-#750#<(0#950361&0-(0#L##
@5%+"2#*,#5775"(,-#75"5<3;(4#%K5+"(00&3,#7"3'3H*2(#75"#%(0#5&+*&%%(0#61(M#<(0#
75-&(,-0#(,#<2-"(00(#70A613%3+&H*(#(;("6(#03*'(,-#*,#(GG(-#positif#0*"#%(*"0#293-&3,0.#
B(0#2-*<(0#<(0#CD#<(",&N"(0#5,,2(0#3,-#(,#(GG(-#<293,-"2#6399(,-#-3*-(#
56*7*,6-*"(#&,G%*(,6(#%5#7"3<*6-&3,4#%K56-&3,#0*"#%(*"0#"26(7-(*"0#(-#%K2%&9&,5-&3,#<(#
-3*0#%(0#neuromédiateurs#63,,*0.#
B3&,#<(#7"3'3H*("#<(0#'5"&5-&3,0#5,5"61&H*(04#%K56*7*,6-*"(#"2-5:%&-#
l’homéostasie#7("-*":2(#75"#615H*(#-"3*:%(#293-&3,,(%.#>,#(GG(-4#%(0#63,6(,-"5-&3,0#(-#
%(0#(GG(-0#0*"#%(0#"26(7-(*"0#<(0#<&GG2"(,-0#,(*"392<&5-(*"0#&97%&H*20#,(#'5"&(,-#H*(#0&#
&%0#03,-#7("-*":204#6399(#%(#<293,-"(#%K5:0(,6(#<K(GG(-#61(M#%(0#'3%3,-5&"(0#05&,0.##
O3*"#0K(,#63,'5&,6"(4#&%#0*GG&-#<K3:0("'("#%(0#93<&G&65-&3,0#neuro?anatomiques#
(-#biochimiques#7"37"(0#5*#0-"(004##P#%K5,;&2-24##P#%5#<27"(00&3,4##P#%K&,039,&(#3*#5*#
0('"5+(#P#<&GG2"(,-(0#<"3+*(0.##
B(0#2-*<(0#06&(,-&G&H*(0#<293,-"(,-#6399(,-#l’électroacupuncture#93<&G&(#%(0#
6&"6*&-0#,(*"3I5,5-39&H*(0#(-#"2+*%(#%(0#'5"&5-&3,0#:&361&9&H*(0#&97%&H*2(0#<5,0#
6156*,#<(#6(0#-"3*:%(0#293-&3,,(%0.##
!5,0#6(0#2-*<(04#%K*-&%&05-&3,#<(#%K2%(6-"356*7*,6-*"(#7("9(-#<(#0-&9*%("#<(0#
73&,-0#<K56*7*,6-*"(#<(#95,&N"(#quantifiable##et#reproductible4#6(#H*&#"273,<#9&(*;#
5*;#6"&-N"(0#<(#%5#7(,02(#06&(,-&G&H*(#366&<(,-5%(.#
#
#
#
#
#
#
#
#
#
#
#
#
#
#
#
#
#
Q&+*"(#R.##S-"(00#(-#,(*"371A0&3%3+&(.#
#
!
Stress!aigu!
!
!
!
!
!
!
!
!
!
!
SNC!
Plasma!
!
1.#NA#
diminue#
#&#5HT#
augmente#
2.#NA#&#Adr##
augmentées#
3.#β#EP#
ACTH#
Cortisol#
4.!Cortisol!
augmenté!
#
#
#
#
#
#
#
!
!
Stress!chronique!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
SNC!
Plasma!
!
4.#Hypercortisolémie#
3.#β#EP#:#tolérance#
&#ACTH#augmenté#
1.!Feed8Back!
interrompu!
!
!
!
5.#Apoptose#
hippocampe#
#
&!
hyperorthosympathisme!
Discussion!des!résultats.!
!
T&361&9&(#<*#0-"(00#(-#2%(6-"356*7*,6-*"(#UG&+*"(#RV.#
#
B3"0#<K*,#0-"(00#5&+*4#%K5;(#1A73-15%593I1A7371A05&"(#(0-#56-&'2.##
)(--(#56-&'5-&3,#(0-#"(073,05:%(#<K*,(#93<&G&65-&3,#<(0#63,6(,-"5-&3,0#(,#,(*"392<&5-(*"0#<5,0#%(#
0A0-N9(#,("'(*;#6(,-"5%#US8)V4#<&GG2"(,-(#<(#%5#93<&G&65-&3,#<(#%(*"#63,6(,-"5-&3,#7%5095-&H*(.##
BK1A73-15%59*0#56-&'(#(,#*,(#G"56-&3,#<(#0(63,<(#%5#026"2-&3,#<K5<"2,5%&,(#U/<"V#(-#<(#
,3"5<"2,5%&,(#U8/V#75"#%5#92<*%%30*""2,5%(.#)(6&#(,-"5W,(#*,(#"256-&3,#&992<&5-(#<(#93:&%&05-&3,#<(0#
"(003*"6(0#<(#%K3"+5,&09(#73*"#G5&"(##G56(#P#%K5+"(00&3,.#
O5"#63,-"(4##<5,0#%(#S8)#%K1A73-15%59*0#7"3'3H*(#%5#<&9&,*-&3,#<(#63,6(,-"5-&3,#<(#%5#8/#(-#
%K5*+9(,-5-&3,#<(#6(%%(#<(#%5#02"3-3,&,(#UXYZV.#[%#0K(,0*&-#%K56-&'5-&3,#<(#%K1&7736597(#(-#<(#%K59A+<5%(4#
+2,2"5-"&6(0#<K5+"(00&'&-2#(-#<K1A7("I5--(,-&3,#G56(#P#%5#9(,56(.##
!(#9J9(4#%K1A73-15%59*0#7"3<*&-#%5#63"-&63-"37&6#"(%50&,+#13"93,(#U)FYV#H*&#56-&'(#%5#026"2-&3,#
<(#7"3I37&3I92%5,3I63"-&,(#UO$@)V#75"#%K1A7371A0(.#B5#O$@)#0(#06&,<(#(,-"(I5*-"(0#(,#/)ZY#(-#(,#β#
(,<3"71&,(0#UβI>OV#H*&#7500(,-#<5,0#%(#63975"-&9(,-#7%5095-&H*(#75"#%(#0A0-N9(#73"-(#1A7371A05&"(.#
BK/)ZY#0-&9*%(#%5#026"2-&3,#<(#63"-&03%#75"#%5#63"-&630*""2,5%(#<5,0#%(#63975"-&9(,-#7%5095-&H*(.#B(0#βI
>O#03,-#<(0#37&5620#(,<3+N,(0#7*&005,-0#H*&#5775"5&00(,-#5'(6#%K/)ZY#(-#%(#63"-&03%#<5,0#%(#7%5095#(-#03,-#
"(073,05:%(#<K*,(#7("6(7-&3,#593&,<"&(#<(#%5#<3*%(*"#5&,0&#H*(#<K(*713"&(#=#6K(0-#6(#H*K3,#577(%%(#
%K5,5%+20&(#<(#0-"(00.##
B(#63"-&03%#<5,0#%5#6&"6*%5-&3,#'5#75"-3*-#<5,0#%K3"+5,&09(.##[%#5&<(#P#"(0-5*"("#%(0#"20("'(0#
2,("+2-&H*(0#(,#72"&712"&(#(,#5+&005,-#0*"#%(0#+"5,<(0#'3&(0#92-5:3%&H*(0.#[%#7500(#<5,0#%(#S8)#75"#%(#
0A0-N9(#73"-(#(-#"25%&0(#*,#"2-"363,-"\%(#&,1&:&-(*"#<(#%K1A73-15%59*0#(-#<(##%K1A7371A0(.#B(0#(GG(-0#<(#%5#
93:&%&05-&3,#<*#0A0-N9(#3"-130A975-1&H*(#<&075"5&00(,-#(,#72"&712"&(4#%K2H*&%&:"(#<(0#63,6(,-"5-&3,0#
&,-"562"2:"5%(0#(,#8/#(-#(,#XYZ#(0-#"2-5:%&4#%5#026"2-&3,#<(#)FY4#<K/)ZY4#<(#βI>O#(-#%5#63"-&03%29&(#
"('&(,,(,-#P#%5#,3"95%(.#
#
B3"0H*(#%(#0-"(00#(0-#61"3,&H*(4#%K#1A7("63"-&03%29&(#"(0-(#5,3"95%(9(,-#7"3%3,+2(.#)(6&#&,1&:(#
%(0#:3*6%(0#<(#"2-"363,-"\%(#,2+5-&G#(;("62(0#75"#%(#63"-&03%#0*"#%K5;(#1A73-15%593I1A7371A05&"(.#B(#
0A0-N9(#0K(9:5%%(4#(,-"(#(,#(;6N0#(-#7"3'3H*(#%K(GG3,<"(9(,-#<(0#"(003*"6(04#%5#93<&G&65-&3,#<(#93&,0#(,#
93&,0#"2'("0&:%(#<(0#6&"6*&-0#&,-"562"2:"5*;#63,6(",20#(-#<(0#63,02H*(,6(0#73*"#-3*-#%K3"+5,&09(.##
BK1A7("56-&'&-2#<(#%K1A73-15%59*0#7"3'3H*(##%K(GG3,<"(9(,-#<(0#63,6(,-"5-&3,0#<(#XYZ#
&,-"562"2:"5%(04#(,-"5W,5,-#-"&0-(00(4#5,;&2-24#-"3*:%(0#<(#63,6(,-"5-&3,.#
BK1A7("56-&'&-2#<(#%K1A7371A0(#(,-"5W,(#*,(#1A7("026"2-&3,#<K/)ZY#(-#<(#βI>O#H*&#G5'3"&0(#%5#
9&0(#(,#7%56(#<(#712,39N,(0#<(#-3%2"5,6(#(-#<(#"20&0-5,6(#5*;#37&5620.#
/#%5#%3,+*(4#6(0#712,39N,(0#7"3'3H*(,-#%K27*&0(9(,-#<(#%5#026"2-&3,#<(#G56-(*"0#
,(*"3-"371&H*(04#6(#H*&#(,-"5W,(#%K5737-30(#<(0#6(%%*%(0#<(#%K1&7736597(#(-#%K1A73G3,6-&3,,(9(,-#<(#
6(%*&I6&.#$,#'(""5#7%*0#%3&,#P#H*(%#73&,-#6(#<(",&("#(0-#&973"-5,-#73*"#<(0#-"3*:%(0#293-&3,,(%0#6399(#
%K5,;&2-2#3*#%5#<27"(00&3,.#
#B5#03%%&6&-5-&3,#7"3%3,+2(#<*#0A0-N9(#3"-130A975-1&H*(#50036&2(#P#%K1A7("63"-&03%29&(#(,-"5W,(#
*,(#-(,<5,6(#P#%K1A7("-(,0&3,#5"-2"&(%%(#(-#P#%5#-561A65"<&(4#P#%K&06129&(#9A365"<&H*(4#5*#<&5:N-(#<(#-A7(#
C4#P#%5#G3,-(#9*06*%5&"(#(-#5*;#-"3*:%(0#&99*,&-5&"(0.#
#
!(0#(;72"&(,6(0#61(M#%(#"5-#3,-#<293,-"2#H*(#%K2%(6-"356*7*,6-*"(#<(#>]^#(-#<(#_C]#"(0-5*"(#
%K2H*&%&:"(#<(0#63,6(,-"5-&3,0#&,-"562"2:"5%(0#(,#XYZ#(-#8/#(,#650#<(#0-"(00#61"3,&H*(.#B5#93;&:*0-&3,#<(#
6(0#9J9(0#73&,-0#(-#<(#!@CD#7"3<*&-#<(0#(GG(-0#0&9&%5&"(0.#BK2%(6-"356*7*,6-*"(#<(#>]^#(-#<(#)E#"(0-5*"(#
%5#026"2-&3,#<(#G56-(*"0#,(*"3-"371&H*(0#(-#"2<*&-#%5#<(0-"*6-&3,#6(%%*%5&"(#<(#%K1&7736597(#(-#<(#
%K59A+<5%(#61(M#<(0#"5-3,0#0-"(0020#<(#95,&N"(#61"3,&H*(#75"#%5#0275"5-&3,#<(#%(*"#9N"(.#
!(#,39:"(*0(0#2-*<(0#6%&,&H*(0#<293,-"(,-#%5#"(%5;5-&3,#<(#75-&(,-0#75"#%#`2%(6-"356*7*,6-*"(#
(,#5+&005,-#0*"#%K1A7371A0(#65"#(%%(0#<293,-"(,-#*,#(GG(-#<(#<&9&,*-&3,#<(0#63,6(,-"5-&3,0#7%5095-&H*(0#
(,#/)ZY4 βI>O#(-#63"-&03%.##
!K5*-"(0#2-*<(0#6%&,&H*(0#9(--(,-#(,#75"5%%N%(#%(0#(GG(-0#:2,2G&H*(0#<(#%K2%(6-"356*7*,6-*"(#<K>]^#
0*"#%(#7"3G&%#<(##-(,0&3,#5"-2"&(%%(#<(#75-&(,-0#0-"(0020#5'(6#*,(#,3"95%&05-&3,#<*#92-5:3%&09(#<(#%5#
0*:0-5,6(#+"&0(#72"&5H*(<*65%(4#<(0#,3A5*;#<*#%36*0#63("*%(*0#(-#<*#"5712#P#%5#F@8#G3,6-&3,,(%%(.#
!(#95,&N"(#0&9&%5&"(4#*,(#5*-"(#2-*<(#6%&,&H*(#9(-#(,#75"5%%N%(#%K592%&3"5-&3,#<*#7"3G&%#<(#-(,0&3,#
5"-2"&(%%(#(-#<(0#063"(0#<(#"(%5;5-&3,#<(#75-&(,-0#0-"(0020#61"3,&H*(0##5'(6#<(0#"A-19(0#
2%(6-"3(,62715%3+"571&H*(0#7%*0#1393+N,(0#(-#7%*0#%(,-0.#
#
Q&+*"(#C.#/,;&2-2#(-#,(*"371A0&3%3+&(.#
#
#
#
!
Anxiété!aiguë!:!le!circuit!de!la!peur!surpasse!celui!du!renforcement!&!du!plaisir!!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
Circuit!de!renforcement!&!du!plaisir!
Circuit!de!la!peur!
1.!Aire!tegmentale!ventrale!:!DA!
2.!Locus!Coeruleus!:!NA!
2.!Noyaux!Raphés!:!5HT!
Rec!5HT2>3!
Rec!5HT1!
3.!CRH!
GABA!
4.!CCK4!
5.!NPY!
#
#
#
#
#
#
!
Anxiété!chronique:!emballement!du!circuit!de!la!peur!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
Circuit!de!renforcement!&!du!plaisir!
Circuit!de!la!peur!
1.!Aire!tegmentale!ventrale!:!DA!
2.!Locus!Coeruleus!:!NA!
2.!Noyaux!Raphés!:!5HT!
Rec!5HT2?3!
Rec!5HT1!
3.!CRH!
GABA!
4.!CCK4!
5.!NPY!
#
#
#
1 / 16 100%
La catégorie de ce document est-elle correcte?
Merci pour votre participation!

Faire une suggestion

Avez-vous trouvé des erreurs dans l'interface ou les textes ? Ou savez-vous comment améliorer l'interface utilisateur de StudyLib ? N'hésitez pas à envoyer vos suggestions. C'est très important pour nous!